The invention relates to monoclonal antibodies to the v3 integrin receptor known to be expressed in large amounts on the surface of osteoclasts and accordingly, associated with bone resorption. The disclosed monoclonal antibodies recognize unique epitopes on v3 and are useful in the treatment of conditions...http://www.google.es/patents/US6359126?utm_source=gb-gplus-sharePatente US6359126 - Antibodies to
